Is Adeshwar Meditex overvalued or undervalued?

As of 29 August 2025, Adeshwar Meditex's valuation grade has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued, with a PE ratio of 12.79, an EV to EBITDA ratio of 8.97, and a Price to Book Value of 0.76. These figures suggest that the stock is trading at a discount compared to its earnings and asset value.
In comparison to its peers, Adeshwar Meditex stands out with a significantly lower PE ratio than Poly Medicure, which has a PE of 59.22, and Blue Jet Health at 32.28. The EV to EBITDA ratio also highlights its attractiveness, as it is much lower than the ratios of its more expensive peers. Notably, while Adeshwar Meditex has faced challenges with a year-to-date return of -29.46%, it has outperformed the Sensex in the past week and month, reinforcing its potential for recovery and growth in the healthcare services sector.